PHB2 promotes colorectal cancer cell proliferation and tumorigenesis through NDUFS1-mediated oxidative phosphorylation.
PHB2 promotes colorectal cancer cell proliferation and tumorigenesis through NDUFS1-mediated oxidative phosphorylation.
复制标题
DOI:
10.1038/s41419-023-05575-9
复制
发表时间:
2023-01-20
影响因子:
9
通讯作者:
Ye, Yan
中科院分区:
文献类型:
--
作者:
Ren, Lin;Meng, Li;Gao, Jing;Lu, Mingdian;Guo, Chengyu;Li, Yunyun;Rong, Ziye;Ye, Yan
The alteration of cellular energy metabolism is a hallmark of colorectal cancer (CRC). Accumulating evidence has suggested oxidative phosphorylation (OXPHOS) is upregulated to meet the demand for energy in tumor initiation and development. However, the role of OXPHOS and its regulatory mechanism in CRC tumorigenesis and progression remain unclear. Here, we reveal that Prohibitin 2 (PHB2) expression is elevated in precancerous adenomas and CRC, which promotes cell proliferation and tumorigenesis of CRC. Additionally, knockdown of PHB2 significantly reduces mitochondrial OXPHOS levels in CRC cells. Meanwhile, NADH:ubiquinone oxidoreductase core subunit S1 (NDUFS1), as a PHB2 binding partner, is screened and identified by co-immunoprecipitation and mass spectrometry. Furthermore, PHB2 directly interacts with NDUFS1 and they co-localize in mitochondria, which facilitates NDUFS1 binding to NADH:ubiquinone oxidoreductase core subunit V1 (NDUFV1), regulating the activity of complex I. Consistently, partial inhibition of complex I activity also abrogates the increased cell proliferation induced by overexpression of PHB2 in normal human intestinal epithelial cells and CRC cells. Collectively, these results indicate that increased PHB2 directly interacts with NDUFS1 to stabilize mitochondrial complex I and enhance its activity, leading to upregulated OXPHOS levels, thereby promoting cell proliferation and tumorigenesis of CRC. Our findings provide a new perspective for understanding CRC energy metabolism, as well as novel intervention strategies for CRC therapeutics.
登录
查看更多内容
DOI:
10.1016/j.bbcan.2018.06.001
发表时间:
2018-08
期刊:
Biochimica et biophysica acta. Reviews on cancer
影响因子:
--
作者:
Labuschagne CF;Zani F;Vousden KH
通讯作者:
Vousden KH
影响因子:
9.7
作者:
Huang, Qi;Chen, Zhigang;Huang, Jian
通讯作者:
Huang, Jian
影响因子:
14.5
作者:
Chen, Kuo;Lu, Pengwei;Aliev, Gjumrakch
通讯作者:
Aliev, Gjumrakch
影响因子:
4.6
作者:
Cheng, Jun;Gao, Feng;Zhou, Lin
通讯作者:
Zhou, Lin
DOI:
10.1186/s13046-022-02465-4
发表时间:
2022-09-02
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
通讯作者:
--